Departments of Bioengineering and Mechanical Engineering, 2210 S. Brook St., Louisville, KY, USA.
Lab Chip. 2013 Mar 7;13(5):892-900. doi: 10.1039/c2lc40663b. Epub 2013 Jan 10.
Nucleated cells in blood like white blood cells (WBCs) and other rare cells including peripheral blood stem cells (PBSCs) and circulating tumor cells (CTCs) possess significant value for patient monitoring and clinical diagnosis. Enrichment of nucleated cells from contaminating red blood cells (RBCs) using label-free techniques without the use of antibodies or centrifugation is highly desirable to ensure minimal cell loss and activation. To accomplish this, we demonstrate proof-of-concept of a new microfluidic technique that combines aqueous phase partitioning with inertial focusing to accomplish enrichment of nucleated cells in blood. This technique exploits selective affinity of RBCs to the dextran phase (DEX) to accomplish initial separation which is amplified by inertial forces that develop in high-aspect-ratio channels. In our experiments, we spiked RBC samples with representative nucleated cells, MOLT-3 cells (human, peripheral blood, T lymphoblast cell line) and MCF-7 cells (human breast cancer cell line) in a ratio of 500 : 1 (RBCs : nucleated cells) and accomplished depletion of ~96% of RBCs while retaining ~98% of nucleated cells. Higher purity can be accomplished by subjecting the enriched nucleated cell mixture to a second pass via the same process. The second pass further enhances RBC depletion (>99% of initial concentration) whereas nucleated cells were recovered without any further loss. This technique therefore has the potential to be utilized either alone or as a sample preparation tool in the clinical and research setting for various clinical and research applications.
血液中的有核细胞,如白细胞 (WBC) 和其他稀有细胞,包括外周血干细胞 (PBSC) 和循环肿瘤细胞 (CTC),对于患者监测和临床诊断具有重要价值。使用无标记技术从污染的红细胞 (RBC) 中富集有核细胞,而不使用抗体或离心,这是非常理想的,以确保最小的细胞损失和激活。为了实现这一目标,我们展示了一种新的微流控技术的概念验证,该技术结合了水相分离和惯性聚焦,以实现血液中有核细胞的富集。该技术利用 RBC 对葡聚糖相 (DEX) 的选择性亲和力来完成初始分离,然后通过在高纵横比通道中产生的惯性力来放大分离。在我们的实验中,我们将代表有核细胞的 MOLT-3 细胞 (人外周血 T 淋巴母细胞系) 和 MCF-7 细胞 (人乳腺癌细胞系) 以 500:1 (RBC:有核细胞) 的比例混入 RBC 样本中,从而实现了 ~96%的 RBC 耗尽,同时保留了 ~98%的有核细胞。通过对富集的有核细胞混合物进行第二次通过相同的过程,可以实现更高的纯度。第二次通过进一步增强了 RBC 的耗尽 (>99%的初始浓度),而有核细胞则没有进一步的损失。因此,该技术有可能单独使用,也可以作为临床和研究环境中的一种样品制备工具,用于各种临床和研究应用。